Gsk (GSK) Inventory Average (2017 - 2025)
Gsk (GSK) has 5 years of Inventory Average data on record, last reported at $7.1 billion in Q4 2024.
- For Q4 2024, Inventory Average rose 9.64% year-over-year to $7.1 billion; the TTM value through Dec 2024 reached $7.1 billion, up 9.64%, while the annual FY2024 figure was $7.0 billion, 6.65% up from the prior year.
- Inventory Average reached $7.1 billion in Q4 2024 per GSK's latest filing, up from $6.4 billion in the prior quarter.
- Across five years, Inventory Average topped out at $7.9 billion in Q4 2021 and bottomed at $6.4 billion in Q4 2023.
- Average Inventory Average over 4 years is $7.1 billion, with a median of $7.0 billion recorded in 2022.
- Peak YoY movement for Inventory Average: decreased 11.97% in 2022, then grew 9.64% in 2024.
- A 4-year view of Inventory Average shows it stood at $7.9 billion in 2021, then fell by 11.97% to $6.9 billion in 2022, then decreased by 7.03% to $6.4 billion in 2023, then rose by 9.64% to $7.1 billion in 2024.
- Per Business Quant database, its latest 3 readings for Inventory Average were $7.1 billion in Q4 2024, $6.4 billion in Q4 2023, and $6.9 billion in Q4 2022.